NOS2 and atherosclerosis: ADMA decreases NO production through competitive inhibition of all NOS isoforms and intracellular arginine transport [10], and differences in circulating ADMA concentrations have been associated with risk for development of essential hypertension, atherosclerosis, and pulmonary vascular disease [32].